text.skipToContent text.skipToNavigation
Pharma & Biotech

You searched for "HUVEC"

Did you mean: hmvec?
49 Products found
  • 1(current)
  • 2
  • 3

You searched for "HUVEC"

650 Documents found
  • Tube Formation Assay with Primary HUVECs
    In this study, we have optimized this assay using Lonza's Primary HUVECs and EGMTM-2 Media
  • TechSheet - Umbilical Vein Endothelial Cell Systems
    Technical information sheet for CloneticsTM HUVEC cells
  • Expanded HUVECs for High-throughput Screening
    HUVECs are a good primary endothelial cell type for many in vitro studies and also for several high-throughput screening applications. Consequently, Lonza offers, HUVEC-XL. These cells are expanded to passage-3 from pooled P1-HUVECs and packaged at 10 million cells per ampoule.
  • Instructions - HUVEC-XLTM Pooled Cell System
    Instructions for culturing CloneticsTM HIVEC-XLTMPooled Cells
  • Transfection Protocol for HUVEC - 96-well ShuttleTM Device
    Instructions of use for transfection of human umbilical vein endothelial cells (Lonza) with the P5 Primary Cell 96-well NucleofectorTM Kit
  • Transfection Protocol for HUVEC - 4D-NucleofectorTM Device
    Instructions of use for transfection of human umbilical vein endothelial cells (Lonza) with the P5 Primary Cell 4D-NucleofectorTM X Kit
  • Lonza Extends Industry-Standard HUVEC Product Line
    Lonza, the market leader in primary cells, has expanded its human primary cell portfolio with an improved version of Human Umbilical Vein Endothelial Cells (HUVEC) cultured in the absence of additive vascular endothelial growth factor (VEGF).
  • Automated Cell Signaling Assays Using Primary HUVECs
    Lonza's Primary HUVECs are an excellent cell type to measure the effects of pharmacologically-important compounds on vial signaling pathways, and they provide increased data relevancy compared to cell lines.
  • Transfection Protocol for HUVEC - NucleofectorTM I/II/2b Device Series
    Instructions of use for transfection of human umbilical vein endothelial cells with NucleofectorTM 1/2 Devices (incl. 1, 2b, 2N, 2S) using HUVEC NucleofectorTM Kit-OLD
  • Assessment of the Anti-angiogenic Effect of VEGFR2 siRNA in HUVEC
    Scientific poster for AACR 2015
  • First siRNA Library Screening in Hard-to-Transfect HUVEC and Jurkat Cells
    High throughput transfection of siRNA libraries has become a valuable tool in target identifi cation and validation. However, such screenings have so far been constrained to mostly easy-totransfect adherent cell lines. Lonza’s 96-well Shuttle® System, based on the well-established Amaxa® Nucleofector® Technology, extends these approaches to primary and diffi cult-to-transfect cells.
  • Assessment of the Anti-Angiogenic Effect of VEGFR2 siRNA in HUVEC Using the NucleofectorTM Technology
    In the White Paper we show the use of our NucleofectorTM Technology to transfect single-donor CloneticsTM HUVEC with siRNA directed against Vascular Endothelial Growth Factor Receptor 2 (VEGFR2). .
  • Transfection Protocol for HUVEC (Lonza) - NucleofectorTM I/II/2b Device Series
    Instructions of use for transfection of human umbilical vein endothelial cells (Lonza) with NucleofectorTM 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • Instructions & Technical Info - Endothelial Cell Systems
    Technical Information and Instructions for Proper Use of Endothelial Cells
  • HMVEC-L calcium biosensor
    This document shows how to use HMVEC-L Calcium Biosensors that are transiently transfected with the i-Photina® calcium-dependent photoprotein.
  • From Drug Discovery to Manufacturing – Solving Your Primary Cell Culture Challenges
    This presentation discusses how and why Lonza's primary cells and media and support team can help researchers from drug discovery to manufacturing to overcome their cell culture challenges.
  • Viable Cells - Proliferating CloneticsTM Cells Chart
    Lonza_ProductDataSheets_Viable_Cells_-_Lonza_Clonetics_Proliferating_Cells_Chart.pdf
  • Respiratory and Cardiovascular Research – Tools for Biologically Relevant Results
    Learn how Lonza supports your respiratory and cardiovascular research
  • Primary Cell Types Provide a Ready-to-Use Platform for Cell-Based Assays
    Poster presented at Miptec, Basel (CH) - Sep 21-24, 2010
  • Cell-based Assays Using Hard-to-transfect Cell Lines and Transiently Transfected Primary Cells
    Co-sponsered poster with Promega
  • 1(current)
  • 2
  • 3

You searched for "HUVEC"

6 Results found
We use cookies to deliver the best service to you. By continuing to browse the site, you are agreeing to our use of cookies.Ok